| 1 |
Zia Z, Iqbal QZ, Ruggiero RA, et al. A rare case of renal sarcoidosis [J]. Cureus, 2021,13(6): e15494.
|
| 2 |
Sikjær MG, Hilberg O, Ibsen R, et al. Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up [J]. Resp Med, 2021,187: 106548.
|
| 3 |
Hena KM. Sarcoidosis epidemiology: race matters [J]. Front Immunol, 2020,11: 537382.
|
| 4 |
Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors [J]. Curr Opin Pulm Med, 2020,26(5): 527-534.
|
| 5 |
Calatroni M, Moroni G, Ponticelli C. Renal replacement therapy in sarcoidosis [J]. Front Med, 2023,9: 990252.
|
| 6 |
Calatroni M, Moroni G, Reggiani F, et al. Renal sarcoidosis [J]. J Nephrol, 2022,36(1): 5-15.
|
| 7 |
Mehta S, Lightle A, Judson MA. Renal sarcoidosis [J]. Nephrol Dial Transpl, 2023,38(4): 803-810.
|
| 8 |
Ramos-Casals M, Kostov B, Brito-Zerón P, et al. How the frequency and phenotype of sarcoidosis is driven by environmental determinants [J]. LUNG, 2019,197(4): 427-436.
|
| 9 |
Grunewald J, Grutters J C, Arkema E V, et al. Sarcoidosis [J]. Nat Rev Dis Primers, 2019,5(1): 45.
|
| 10 |
Lee S, Birnie D, Dwivedi G. Current perspectives on the immunopathogenesis of sarcoidosis [J]. Respir Med, 2020,173: 106161.
|
| 11 |
Zhou ER, Arce S. Key players and biomarkers of the adaptive immune system in the pathogenesis of sarcoidosis [J]. Int J Mol Sci, 2020,21(19): 7398.
|
| 12 |
Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis [J]. Curr Opin Hematol, 2017,24(1): 59-65.
|
| 13 |
Brandao C M, Montezinho S, Teixeira A M, et al. Sarcoidosis with rare extrapulmonary involvement [J]. Eur J Case Rep Intern Med, 2021,8(7): 002540.
|
| 14 |
刘立旻, 郑黎晖, 张涛, 等. 孤立型心脏结节病一例并文献复习 [J/OL]. 中华临床医师杂志(电子版), 2022,16(2): 193-196.
|
| 15 |
Wang W, Ma Y, Zhang Y, et al. Diagnostic and staging value of serum angiotensin-converting enzyme in sarcoidosis [J]. Comput Math Methods Med, 2022: 4657502.
|
| 16 |
Bennett D, Cameli P, Lanzarone N, et al. Correction to: chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis [J]. Respir Res, 2020,21(1): 34.
|
| 17 |
Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline [J]. Am J Resp Crit Case, 2020,201(8): e26-e51.
|
| 18 |
Ueda S, Murakami T, Ogino H, et al. Systemic sarcoidosis presenting with renal involvement caused by various sarcoidosis-associated pathophysiological conditions [J]. Internal Med, 2019,58(5): 679-684.
|
| 19 |
Kiani A, Abedini A, Adcock IM, et al. Association between vitamin D deficiencies in sarcoidosis with disease activity, course of disease and stages of lung involvements [J]. J Med Biochem, 2018,37(2): 103-109.
|
| 20 |
Calatroni M, Moroni G, Ponticelli C. Renal replacement therapy in sarcoidosis [J]. Front Med (Lausanne), 2023,9: 990252.
|
| 21 |
Sherer BA, Chen L, Kang M, et al. A continuum of mineralization from human renal pyramid to stones on stems [J]. Acta Biomater, 2018,71: 72-85.
|
| 22 |
Fogo AB, Lusco MA, Najafian B, et al. Atlas of renal pathology: sarcoidosis [J]. Am J Kidney Dis, 2016,68(1): e5-6.
|
| 23 |
Bush A, Pabary R. Grappling with the granuloma: where is thee ACE in the hole? [J]. Thorax, 2022,77(4): 320-321.
|
| 24 |
Bagnasco SM, Gottipati S, Kraus E, et a1. Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course [J]. PLOS One, 2014,9(10): e10778．
|
| 25 |
Löffler C, Löffler U, Tuleweit A, et al. Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients [J]. Sarcoidosis Vasc Dif. 2015,31(4): 306-315.
|
| 26 |
Janssen U, Naderi S, Amann K. Idiopathic granulomatous interstitial nephritis and isolated renal sarcoidosis: Two diagnoses of exclusion [J]. SAGE Open Med, 2021,9: 20503121211038470.
|
| 27 |
刘宇鑫, 王倩, 刘茂东, 等. 结节病肾损害临床病理分析3例 [J]. 中华风湿病学杂志, 2023,27(8): 553-556.
|
| 28 |
Zammouri A, Barbouch S, Najjar M, et al. Tubulointer-stitial nephritis due to sarcoidosis: clinical, laboratory, and histological features and outcome in a cohort of 24 patients [J]. Saudi J Kidney Dis T, 2019,30(6): 1276-1284.
|
| 29 |
Bergner R, Löffler C. Renal sarcoidosis: approach to diagnosis and management [J]. Curr Opin Pulm Med, 2018,24(5): 513-520.
|
| 30 |
Thillai M, Atkins CP, Crawshaw A, et al. BTS Clinical Statement on pulmonary sarcoidosis [J]. Thorax, 2021,76 (1): 4-20.
|
| 31 |
Veltkamp M, Drent M, Baughman RP. Infliximab or biosimilars in sarcoidosis: to switch or not to switch? [J]. Sarcoidosis Vasc Dif, 2016,32(4): 280-283.
|
| 32 |
Cinetto F, Compagno N, Scarpa R, et al. Rituximab in refractory sarcoidosis: a single centre experience [J]. Clin Mol Allergy, 2015,13(1): 19.
|
| 33 |
Jeny F, Bernaudin JF, Valeyre D, et al. Hypoxia promotes a mixed inflammatory-fibrotic macrophages phenotype in active sarcoidosis [J]. Front Immunol, 2021,12: 719009.
|
| 34 |
Aouizerate J, Matignon M, Kamar N, et al. Renal transplantation in patients with sarcoidosis: a French multicenter study [J]. Clin J Am Soc Nephrol, 2010,5(11): 2101-2108.
|
| 35 |
Gorsane I, Zammouri A, Hajji M, et al. Renal involvement in sarcoidosis: prognostic and predictive factors [J]. Nephrol Ther, 2021,18(1): 52-58.
|
| 36 |
Mahevas M, Lescure FX, Boffa JJ. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients [J]. Medicine (Baltimore), 2009,88(2): 98-106.
|